BOSTON – JLL has appointed Travis McCready as executive director and national practice leader within its life sciences practice.
Within his new role, McCready will partner with and connect local market teams throughout the US, as part of JLL's life sciences strategy. He will additionally serve as an advisor to clients; providing the full spectrum of JLL's life sciences real estate services.
Aiming to capitalize on the robust worldwide prescription drug market, which is expected to surpass $1 trillion by 2022, JLL intends for McCready to assist clients in optimizing their portfolios as they quickly develop COVID-19 related vaccines. With new life sciences hubs emerging throughout the nation, McCready will work with clients throughout the nation.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Ingrid Tunberg
Ingrid Tunberg sits on the editorial team as a coordinator and reporter for Real Estate Forum and GlobeSt.com. She is responsible for writing stories, assisting with industry awards and marketing nomination events. Previously, Ingrid worked as a copywriter across various industries throughout New York City and Chicago.
